Search for Clinical Trial Results
Limb-girdle Muscular Dystrophy Type 2I - 1 Studies Found
| Status | Study |
| RECRUITING |
Study Name: Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) Condition: Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) Date: 2024-12-01 Interventions: The BBP-418 drug product is provided as Granules for Oral solution consisting of BBP-418 drug substance and silicon dioxide in a multilaminate sachet |